Tumour molecular profiling for deciding therapy-the French initiative.
作者： Frédérique Nowak , Jean-Charles Soria , Fabien Calvo
DOI: 10.1038/NRCLINONC.2012.42
关键词: Targeted therapy 、 Routine clinical practice 、 Medical physics 、 Medicine 、 Therapeutic decision making 、 Molecular diagnostics 、 Profiling (information science) 、 Christian ministry 、 Pathology
摘要: … treatment will soon be guided by the determination of an increasing number of biomarkers for an increasing number … recommendations for the implementation of new molecular tests, …
nature.com
sci-hub.se 参考文章(50)
Ligue contre le cancer Comité de la Corrèze, Institut National du Cancer ,(2012)
Gilberto de Lima Lopes, Joel E. Segel, Daniel S. W. Tan, Young K. Do, Tony Mok, Eric A. Finkelstein, Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung Cancer. ,vol. 118, pp. 1032- 1039 ,(2012) , 10.1002/CNCR.26372
A. -M. Bouvier, A. -V. Guizard, B. Tretarre, G. Launoy, M. Colonna, A. Danzon, F. Molinie, X. Troussard, O. Ganry, P. -M. Carli, A. Jaffré, C. Bessaguet, E. Sauleau, C. Schvartz, P. Arveux, M. Maynadié, P. Grosclaude, J. Estève, J. Faivre, N. Bossard, M. Velten, L. Remontet, A. Belot, S. Bara, Survie des patients atteints de cancer en France: principaux résultats de la première étude du réseau des registres français des cancers (Francim) Oncologie. ,vol. 9, pp. 574- 580 ,(2007) , 10.1007/S10269-007-0721-2
Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber, Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer. ,vol. 7, pp. 169- 181 ,(2007) , 10.1038/NRC2088
Erin E. Mancl, Jill M. Kolesar, Lee C. Vermeulen, Clinical and economic value of screening for Kras mutations as predictors of response to epidermal growth factor receptor inhibitors American Journal of Health-system Pharmacy. ,vol. 66, pp. 2105- 2112 ,(2009) , 10.2146/AJHP090036
Ali Torkamani, Gennady Verkhivker, Nicholas J. Schork, Cancer driver mutations in protein kinase genes. Cancer Letters. ,vol. 281, pp. 117- 127 ,(2009) , 10.1016/J.CANLET.2008.11.008
Magnus Sundström, Karolina Edlund, Monica Lindell, Bengt Glimelius, Helgi Birgisson, Patrick Micke, Johan Botling, KRAS analysis in colorectal carcinoma: Analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice BMC Cancer. ,vol. 10, pp. 660- 660 ,(2010) , 10.1186/1471-2407-10-660
Sandrine Magnin, Erika Viel, Alice Baraquin, Severine Valmary-Degano, Bernadette Kantelip, Jean-Luc Pretet, Christiane Mougin, Marthe Bigand, Benoît Girardo, Christophe Borg, Christophe Ferrand, A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers The Journal of Molecular Diagnostics. ,vol. 13, pp. 485- 492 ,(2011) , 10.1016/J.JMOLDX.2011.05.010
E Rouleau, F Spyratos, B Dieumegard, J M Guinebretière, R Lidereau, I Bièche, KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition. British Journal of Cancer. ,vol. 99, pp. 2100- 2100 ,(2008) , 10.1038/SJ.BJC.6604815
E S K Ma, C L P Wong, F B F Law, W-K Chan, D Siu, Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis. Journal of Clinical Pathology. ,vol. 62, pp. 886- 891 ,(2009) , 10.1136/JCP.2008.063677